Symposium

[S37] The 4th current status of reverse translational research conducted by hospital pharmacists ~ Novel pharmacotherapy from a perspective of clinical pharmacist ~

Sat. Mar 28, 2020 9:00 AM - 11:00 AM [Room B] Room B-1 (2F)

Organizers: Satohiro Masuda (IUHW Narita Hosp Dept Pharmacy), Hiroki Itoh (Oita Univ Hosp, Dept Pharm), Ryuji Ikeda (Univ Miyazaki Hosp Dept Pharmacy), Hirofumi Jono (Kumamoto Univ Hosp, Dept Pharmacy)

With innovative advancements in science and technology, large numbers of therapeutic target molecules have recently been identified. Although molecular-targeted agents that modulate the function of target molecules have been widely used in clinical settings, multiple trials and errors are often necessary for proper medication due to a lack of enough clinical evidence. Therefore, clinical pharmacists are required to provide novel clinical evidence in medical settings.
In this symposium, we would like to present the latest topics and their backgrounds concerning the basic and clinical research conducted by clinical pharmacists working in clinical settings, and discuss the current status of research conducted by hospital pharmacists, their issues, and future development, in order to consider the meaning and importance of research activities.

+Add all to schedule

9:00 AM - 9:05 AM

[S37-Opening] オーガナイザー挨拶

増田智先¹ (1. 国際医療福祉大病院薬)

9:05 AM - 9:30 AM

[S37-1] Development of nucleic acid medicines from clinical site

○Yukinobu Kodama¹, Hitoshi Sasaki¹ (1. Dept. of Hosp. Pharm. Nagasaki Univ. Hosp.)

9:30 AM - 9:55 AM

[S37-2] Cell death-mediated renal fibrosis in drug-induced nephropathy

○Shunsaku Nakagawa¹ (1. Department of Clinical Pharmacology & Therapeutics, Kyoto University Hospital)

9:55 AM - 10:20 AM

[S37-3] Search for preventive drugs against oxaliplatin-induced peripheral neuropathy using a large-scale medical information

○Mitsuhiro Goda^1,2, Yoshito Zamami^1,2, Takahiro Niimura², Takehiro Kawashiri³, Kenshi Takechi⁴, Masayuki Chuma⁴, Masafumi Kayano¹, Hiroaki Hamano¹, Naoto Okada¹, Daisuke Kobayashi³, Takao Shimazoe³, Yuki Izawa-Ishizawa⁵, Keisuke Ishizawa^1,2 (1. Dept. Pharm., Tokushima Univ. Hosp., 2. Dept. Clin. Pharmacol. Ther., Grad. Sch. Biomed. Sci., Tokushima Univ., 3. Dept. Clin. Pharm. Pharma. Care, Grad. Sch. Pharma. Sci., Kyushu Univ., 4. Clin. Trial Ctr. Developmental Therap., Tokushima Univ. Hosp., 5. AWA Support Ctr, Tokushima Univ.)

10:20 AM - 10:45 AM

[S37-4] Development of a novel therapeutic strategy for antimicrobial resistant bacteria based on measurement of blood beta lactams concentrations

○Kazutaka Oda^1,2, Hirofumi Jono¹, Kisato Nosaka², Hideyuki Saito¹ (1. Dept. of Pharm., Kumamoto Univ. Hosp., 2. Dept. of Infect. Con., Kumamoto Univ. Hosp.)

10:45 AM - 11:00 AM

[S37-Closing] 総括

城野博史¹ (1. 熊本大病院薬)

Session information